These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9551030

  • 1. Physician specialty is associated with differences in warfarin use for atrial fibrillation.
    Kellen JC, Russell ML.
    Can J Cardiol; 1998 Mar; 14(3):365-8. PubMed ID: 9551030
    [Abstract] [Full Text] [Related]

  • 2. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [Abstract] [Full Text] [Related]

  • 3. The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.
    Bungard TJ, Ghali WA, McAlister FA, Buchan AM, Cave AJ, Hamilton PG, Mitchell LB, Shuaib A, Teo KK, Tsuyuki RT.
    Can J Cardiol; 2003 Mar 15; 19(3):280-4. PubMed ID: 12677283
    [Abstract] [Full Text] [Related]

  • 4. National patterns of warfarin use in atrial fibrillation.
    Stafford RS, Singer DE.
    Arch Intern Med; 2003 Mar 15; 156(22):2537-41. PubMed ID: 8951296
    [Abstract] [Full Text] [Related]

  • 5. Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project.
    Chang HJ, Bell JR, Deroo DB, Kirk JW, Wasson JH.
    Arch Intern Med; 1990 Jan 15; 150(1):83-6. PubMed ID: 2297300
    [Abstract] [Full Text] [Related]

  • 6. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
    Peterson GM, Boom K, Jackson SL, Vial JH.
    Intern Med J; 2002 Jan 15; 32(1-2):15-23. PubMed ID: 11783668
    [Abstract] [Full Text] [Related]

  • 7. Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences.
    Pradhan AA, Levine MA.
    Can J Clin Pharmacol; 2002 Jan 15; 9(4):199-202. PubMed ID: 12584578
    [Abstract] [Full Text] [Related]

  • 8. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
    Burkiewicz JS.
    Pharmacotherapy; 2005 Aug 15; 25(8):1062-7. PubMed ID: 16207096
    [Abstract] [Full Text] [Related]

  • 9. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics.
    Choudhry NK, Soumerai SB, Normand SL, Ross-Degnan D, Laupacis A, Anderson GM.
    Am J Med; 2006 Jul 15; 119(7):607-15. PubMed ID: 16828633
    [Abstract] [Full Text] [Related]

  • 10. Stroke prevention in atrial fibrillation: are we following the guidelines?
    Pusser BE, Robertson SL, Robinson MD, Barton C, Dobson LA.
    N C Med J; 2005 Jul 15; 66(1):9-13. PubMed ID: 15786672
    [Abstract] [Full Text] [Related]

  • 11. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands--The EXAMINE-AF study. A questionnaire survey.
    Dinh T, Nieuwlaat R, Tieleman RG, Büller HR, van Charante NA, Prins MH, Crijns HJ.
    Int J Clin Pract; 2007 Jan 15; 61(1):24-31. PubMed ID: 17229177
    [Abstract] [Full Text] [Related]

  • 12. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.
    McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett EL.
    Arch Intern Med; 1995 Feb 13; 155(3):277-81. PubMed ID: 7832599
    [Abstract] [Full Text] [Related]

  • 13. 'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation.
    Anderson N, Fuller R, Dudley N.
    QJM; 2007 May 13; 100(5):263-9. PubMed ID: 17389657
    [Abstract] [Full Text] [Related]

  • 14. Atrial fibrillation in the elderly: physicians' attitudes to anticoagulation.
    King D, Davies KN, Slee A, Silas JH.
    Br J Clin Pract; 1995 May 13; 49(3):123-5. PubMed ID: 7779660
    [Abstract] [Full Text] [Related]

  • 15. Preventing stroke in people with atrial fibrillation: a cross-sectional study.
    de Lusignan S, van Vlymen J, Hague N, Thana L, Dzregah B, Chan T.
    J Public Health (Oxf); 2005 Mar 13; 27(1):85-92. PubMed ID: 15590708
    [Abstract] [Full Text] [Related]

  • 16. Clinical correlation between effective anticoagulants and risk of stroke: are we using evidence-based strategies?
    Rahimi AR, Wrights B, Akhondi H, Richard CM.
    South Med J; 2004 Oct 13; 97(10):924-31. PubMed ID: 15558915
    [Abstract] [Full Text] [Related]

  • 17. [Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].
    Han W, Shen DT, Wang YM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun 13; 26(6):851-2, 855. PubMed ID: 16793618
    [Abstract] [Full Text] [Related]

  • 18. Ethical decision making by family physicians.
    Dayringer R, Paiva RE, Davidson GW.
    J Fam Pract; 1983 Aug 13; 17(2):267-72. PubMed ID: 6683747
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. People aged over 75 in atrial fibrillation on warfarin: the rate of major hemorrhage and stroke in more than 500 patient-years of follow-up.
    Johnson CE, Lim WK, Workman BS.
    J Am Geriatr Soc; 2005 Apr 13; 53(4):655-9. PubMed ID: 15817013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.